Cognitive decline and anxiety symptoms commonly co-occur in later life, but the temporal order of changes on these two attributes is unclear. Specifically, it is unknown if greater anxiety leads to subsequent declines in cognitive performance or if worse cognitive performance leads to increased anxiety. In this study, we sought to elucidate the temporal dynamics between anxiety symptoms and cognitive performance across old age-that is, the extent to which level and change in one variable influence subsequent changes in a second variable. We examined data from 721 nondemented participants from the Swedish Adoption/Twin Study of Aging. Participants completed as many as eight assessments of cognitive performance and anxiety over a 26-year period. Bivariate dual-change score models were fit to examine the dynamic association between anxiety and cognitive performance. Bidirectional associations between anxiety and cognitive performance were found among measures of processing speed, attention, and memory but not visuospatial abilities. Higher anxiety was associated with greater declines in processing speed over the duration of 6 years and worsening attention over a span of 3 years. The reverse direction was also significant in that slower processing speed, worse attention, and poorer nonverbal and working memory performance were associated with larger increases in anxiety 3 years later. These findings highlight that in cognitively intact older adults, the association between anxiety and worse cognitive performance is bidirectional and complex.
Dementia and cognitive decline are common in later life (Hebert, Weuve, Scherr, & Evans, 2013) , are debilitating, and carry a significant public health cost (Hurd, Martorell, & Langa, 2013) . As no significantly effective treatments currently exist for dementia, there is a focus on identifying potentially modifiable risk factors in order to develop successful interventions to prevent or delay decline.
Anxiety symptoms and disorders are the most prevalent psychiatric conditions in later life. As many as 14% of older adults meet diagnostic criteria for an anxiety disorder, and 32% experience clinically significant symptoms of anxiety (Braam et al., 2014; WolitzkyTaylor, Castriotta, Lenze, Stanley, & Craske, 2010) . Higher anxiety in later life is associated with adverse health outcomes such as myocardial infarction (Annelieke et al., 2012) , death ideation (Van Orden, Simning, Conwell, Skoog, & Waern, 2013) , functional impairment (Brenes et al., 2008; Porensky et al., 2009) , greater use of health care resources (Porensky et al., 2009; Vasiliadis et al., 2013) , and placement in a nursing home (Gibbons et al., 2002) .
Not only are both cognitive decline and anxiety symptoms common in later life, but they also often co-occur (Beaudreau & O'Hara, 2008) . This co-occurrence is important as anxiety may serve as a potentially modifiable risk factor for declining cognitive performance. The cognitive domains most associated with anxiety are processing speed, attention, memory, and executive functioning. Cross-sectional examinations with community-dwelling older adults document higher state anxiety symptoms being associated with worse learning and memory (Bierman, Comijs, Jonker, & Beekman, 2005) and executive functioning (Booth, Schinka, Brown, Mortimer, & Borenstein, 2006) . Similarly, Beaudreau and O'Hara (2009) found that increased symptoms of anxiety were associated with slower processing speed and worse executive functioning, independent of depressive symptoms. The association between anxiety and worse cognitive performance has also been found in physically frail, homebound older adults (Petkus, Gum, & Wetherell, 2013) .
Longitudinal studies provide further evidence that anxiety symptoms and disorders are associated with poorer cognitive performance, as well as greater declines over time. Compared with those not experiencing anxiety symptoms, community-dwelling older adults experiencing mild worry symptoms had worse performance on list learning tasks, as well as greater declines in that domain over the following 2 years (Pietrzak et al., 2012) . Anxiety symptoms and disorders also appear to be associated with increased risk of developing neurocognitive disorders, such as mild cognitive impairment or dementia (Burton, Campbell, Jordan, Strauss, & Mallen, 2013; Yaffe et al., 2010) . Taken together, the evidence from cross-sectional and longitudinal studies documents anxiety symptoms and disorders to be negatively associated with cognitive performance and possible risk factors for future cognitive decline.
Many longitudinal studies make inferences of directionality, although they are not designed to yield these conclusions. Thus, Figure 1 . Diagram of the full bivariate dual-change score model examining changes in anxiety and changes in cognitive performance. Note that this model only depicts predicted level and change of anxiety and each cognitive score from ages 50 -59. The full model estimated continues through age 86 -89 years. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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the directionality of the association between anxiety and cognitive performance remains unclear. One hypothesis is that higher anxiety leads to worse cognitive performance with the other hypothesis being that worse cognitive performance leads to higher anxiety. Individuals with anxiety disorders may exhibit a disruption of the hypothalamic-pituitary-adrenal (HPA) axis (Mantella et al., 2008) . HPA axis dysfunction is frequently associated with changes in cortisol levels, which may lead to damage of the hippocampus (Lupien et al., 1998) , resulting in deficits in learning and memory. Treatment for late-life anxiety may decrease putative HPA axis overactivation (Lenze et al., 2011) , and decreases in cortisol have been found to be correlated with improvements in memory (Lenze et al., 2012) . On the other hand, cortisol levels have also been associated with other cognitive abilities such as executive function This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
and processing speed (Franz et al., 2011) . Anxiety symptoms have also predicted increased rates of atrophy of the insular cortex, an important brain structure associated with memory, in individuals with amnestic mild cognitive impairment (Mah et al., 2015) . Anxiety may moderate the negative effect of Alzheimer's disease pathology, specifically amyloid-beta; in a longitudinal study, individuals with both mild anxiety symptoms and high amyloid-beta accumulation experienced greater declines in cognitive functioning compared to individuals who had only one of these risk factors (Pietrzak et al., 2015) . Taken together, these studies support the hypothesis that anxiety may lead to declines in cognitive performance over time.
Reverse causality is also possible in that worsening cognitive performance may lead to subsequent increases in anxiety. Declining abilities may become a source of worry and anxiety in older adults. Older adults are more likely to worry about developmentally salient factors, such as physical and cognitive health (Gould & Edelstein, 2010; Wetherell, Le Roux, & Gatz, 2003) . Additionally, problem solving is an important type of cognitive functioning (Burton, Strauss, Bunce, Hunter, & Hultsch, 2009; Burton, Strauss, Hultsch, & Hunter, 2006 ) directly related to stress and anxiety. Deficits in problem solving may result in decreased ability to effectively resolve current problems or prevent stressors from arising in the future. This inability to adequately solve problems may in turn result in the development of anxiety. Research supports this hypothesis in that neuroticism, a personality trait associated with anxiety, was increased in individuals subsequent to new-onset mild cognitive impairment (Waggel et al., 2015) . It is also possible that a bidirectional association is present in that anxiety leads to subsequent declines in cognitive performance while worse cognitive performance leads to subsequently higher anxiety. Even the putative cortisol-cognition association may be bidirectional. For example, Franz et al. (2011) found that cortisol levels were negatively associated with cognitive performance in midlife, but they also showed that general cognitive ability at age 20 predicted midlife cortisol levels 35 years later.
Anxiety may have a cumulative negative effect over time, thus making the length of follow-up period important for studies examining anxiety and cognitive performance across later life. The effect of possible mechanisms linking anxiety and cognition explained previously (e.g., HPA dysfunction, inflammation, amyloid-beta) are most likely small but could exert a cumulative effect over time. The negative effect of anxiety on cognitive performance may be too small to detect over a short period; however, the effect may become larger with a greater length of time and extended exposure. Studies examining the association between depressive symptoms and risk of dementia find a stronger association when examined over a longer follow-up period compared to a shorter period (Byers & Yaffe, 2011) . A similar relationship may be found with anxiety symptoms. In a previous analysis from our group, we found that anxiety symptoms in healthy, older Swedish twins were asso- ciated with increased risk of dementia over a 28-year follow-up period and cognitive decline when examined over a 26-year follow-up period . However, in an earlier report examining the same data when only 6 years of follow-up data were available, there was no significant longitudinal association (Wetherell, Reynolds, Gatz, & Pedersen, 2002) . Statistical explanations are also possible: Greater individual variability in cognitive changes over a longer period of time may result in greater likelihood of detecting an association between anxiety and cognitive changes. In summary, past research, including from our group, has found an association between anxiety symptoms and cognitive performance in later life. This past research has not elucidated the directionality of this association. Past research also has not directly tested the question regarding length of follow-up period. Given these unanswered questions, we examined change in anxiety and cognitive performance over multiple short (3-year) and long (6-year) time periods using a method that is designed specifically to address the temporal order of these changes. The 3-year follow-up period corresponds to change over one wave, whereas the 6-year follow-up corresponds to change over two waves of assessment. This question has remained unresolved because it can only be answered with a long-term longitudinal study with multiple assessments over time. Here we examine such a study.
Method Participants
Participants included 721 twins from the Swedish Adoption/ Twin Study of Aging (SATSA; Finkel & Pedersen, 2004) . SATSA contains all twins from the Swedish registry who were separated and reared apart before the age of 11, as well as twins reared together who were matched with the twins reared apart on gender, county of birth, and age. In 1986, a subsample of those twins from SATSA age 50 or older completed an inperson assessment of cognitive ability, referred to as IPT1 (first in-person testing) one. Participants completed subsequent IPT follow-up assessments approximately every 3 years. Participants in SATSA who were younger than 50 years at the first in-person assessment but turned 50 during the follow-up period were invited to complete an IPT assessment upon their 50th birthday. The assessment schedule was as follows: IPT1, 1986 IPT1, -1988 IPT2, 1989 IPT2, -1991 IPT3, 1992 IPT3, -1994 IPT5, 1999 IPT5, -2001 IPT6, 2002 IPT6, -2004 IPT7, 2005 IPT7, -2007 IPT8, 2008 IPT8, -2010 and IPT9, 2010 -2012 . Due to gaps in funding, IPT4 was conducted over the phone and therefore no cognitive or anxiety data were collected. Anxiety was not measured at IPT1 so participants may have completed up to seven anxiety assessments and eight cognitive assessments over the span of the 26-year study period. Our interest in SATSA was the longitudinal nature of the study, 
The 3-year coupling represents change over a 3-year period and 6-year coupling represents change over a 6-year period. Est represents parameter estimate. CFI ϭ comparative fit index; RMSEA ϭ root mean square error of approximation.
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having multiple waves of assessment over a long follow-up period. In the present report, we focus on phenotypic associations between anxiety and cognitive performance, not questions of heritability. SATSA was approved by the Ethics Committee at Karolinska Institutet. All participants provided informed consent for participation.
Measures
Anxiety. Anxiety symptoms were measured using an anxiety scale called the Anxiety Personality Questionnaire (APQ; . The measure of anxiety available in the IPTs was the neuroticism scale from the Eysenck Personality inventory (EPI; Eysenck & Eysenck, 1968) . The APQ was derived via Rausch data harmonization between the EPI and the State Anxiety Scale from the State Trait Personality Inventory (STPI; Spielberger, 1979) to identify an anxiety scale composed of items from the EPI best measuring anxiety. The phenotypic mean and genetic and environmental contributions to the APQ were similar to the STPI, suggesting that the APQ is a valid measure of anxiety . The correlation between the APQ and STPI was 0.57.
Cognitive measures. Tests of processing speed, attention, and working memory were the main cognitive measures of interest. The cognitive battery also consisted of tests of nonverbal memory and visuospatial abilities, which were included in our analyses. Figure Identification Test. For the Symbol Digit Test, participants were presented with symbols and asked to verbally report digits that correspond to the symbols . The Figure  Identification Test (Dureman, Kebbon, & Osterberg, 1971 ) measures processing speed and attention. It consists of a 60-item pattern-matching test and participants report which pattern matches 5 possible target patterns.
Processing speed. Processing speed was measured with the Symbol Digit Test and the
Memory. The Thurstone Picture Memory test was used to measure nonverbal episodic memory (Dureman et al., 1971) . Participants were presented with 28 drawings of items for 5 s each. They were then asked to recognize which items they had previously seen.
Attention/working memory. Attention and working memory were assessed using the Digit Span test (Jonsson & Molander, 1964) . Participants are asked to repeat strings of three to nine digits forward and backward. The final score is the sum of the highest number of digits the participant can recall forward and backward. Digit Span Forward is a measure of attention, whereas Digit Span Backward measures both attention and working memory (Ramsay & Reynolds, 1995) . In this study, we analyzed Digit Span Forward and Digit Span Backward separately.
Visuospatial abilities. The Koh's Block Design test (Dureman et al., 1971 ) and the Card Rotations test (Ekstrom, French, Note. Coupling Anx ¡ Thur ϭ coupling parameter ␥ ANX‫ء‬THURSTONE ; Coupling Thurstone ¡ Anx ϭ coupling parameter ␥ THURSTONE‫ء‬ANX . The 3-year coupling represents change over a 3-year period and 6-year coupling represents change over a 6-year period. Est represents parameter estimate. CFI ϭ comparative fit index; RMSEA ϭ root mean square error of approximation.
& Harman, 1976) were administered to assess visuospatial abilities. The Block Design task is similar to the Wechsler Adult Intelligence Scale (WAIS) Block Design task. Participants use blocks to create seven designs. Each item is scored from 0 -6 based on the amount of time taken to complete the design. For Card Rotations, participants are given a target design followed by four items. Participants then determine which of the items was a rotated form of the target. Possible scores range from 0 -112. The whole Card Rotation test was not administered during IPT9, so data are only available for seven measurement points. Physical illness. Physical illness was indexed by a count of the number of organ systems affected by medical illness at the first assessment. Scores range from 0 -13 and include disease in organ systems, including cardiovascular, respiratory, musculoskeletal, and central nervous system. This score has been used in prior SATSA studies (Harris, Pedersen, McClearn, Plomin, & Nesselroade, 1992) .
Depressive symptoms. Depressive symptoms were measured using the Center for Epidemiological Studies Depression (CESD) Scale at the first time this was assessed (Radloff, 1977) .
Statistical Analysis
Description of dual-change score models. Advances in structural equation modeling allow for the examination of the longitudinal dynamic association between two variables (McArdle & Hamagami, 2003) . These models enable quantification of how the level of one variable is associated with changes in another variable. In this study, we fit bivariate dual-change score models (DCSMs) to investigate the extent to which level of anxiety was associated with change in cognitive performance over time. The reverse was also examined, that is, the extent to which level of cognitive performance led to changes in anxiety over time. DCSMs have been used in other longitudinal examinations investigating the association between processing speed and other cognitive domains (Finkel, Reynolds, McArdle, & Pedersen, 2007) , openness to experience and cognition (Sharp, Reynolds, Pedersen, & Gatz, 2010) , and depression and cognitive performance (Jajodia & Borders, 2011) . Because participants were twins, data within each twin pair were correlated and the assumption of independence of data was violated. To account for the twin pair dependency, clustering of participants within twin pairs was accounted for across all models. Clustering of data does not impact parameter estimates but does impact the standard errors of each parameter estimate, typically resulting in underestimation. Hence, we applied robust maximum likelihood estimation (MLR) that produced maximum likelihood parameter estimates with robust standard errors calculated with a sandwich estimator.
Data preparation. To aid in the interpretation of the resulting parameters, the APQ scores and cognitive data were standardized This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
into T scores. The mean and standard deviation at the first time these variables were measured were used for standardization. Standardizing both the APQ and the cognitive variables on the same scale aids in the interpretation of the dynamic coupling between the two variables and is common practice in DCSM analyses (Finkel, Reynolds, McArdle, Hamagami, & Pedersen, 2009; Finkel et al., 2007; Infurna, Gerstorf, Ryan, & Smith, 2011) . All participants with at least one anxiety and cognitive assessment were included in each analysis. In all models, age was modeled as a time variable. Three-year age intervals were used to examine age trajectories. This time period was chosen largely due to the structure of the data collection protocol because participants completed assessments approximately every 3 years. Additionally, prior SATSA investigations have utilized a 3-year interval to maximize the age range for which trajectories can be examined (Finkel, Reynolds, McArdle, Gatz, & Pedersen, 2003; Finkel et al., 2009; Finkel et al., 2007) . Thus, age was modeled as 50 -52.99, 53-55.99, 56 -58.99, and so on, up to 86 -88.99. If participants were assessed twice within one age interval, the first assessment was utilized and the second assessment was dropped. Last, possible confounding variables (education, sex, depressive symptoms, and physical health) were added as covariates in the models and regressed upon the latent intercept and slope factors. Models were run with and without these covariates regressed upon the intercept and slope factors to see the impact of the covariates on the parameter estimates from the models. Regressing the intercept and slope on these covariates adjusted the initial level and constant linear change of anxiety and cognitive performance by these variables. DCSM model parameters. Univariate DCSM models were fit to examine the average trajectory and individual differences around change in anxiety and cognitive performance variables separately over age. Bivariate DCSMs were fit next to examine the dynamic associations between anxiety and cognitive performance. Figure 1 provides a conceptual illustration of the full bivariate DCSM. In the univariate models, for the APQ and each cognitive test, linear and nonlinear proportional change was estimated. In the univariate DCSM models, constant linear change is represented with ␣, the slope of the latent factor is represented as y s , and ␤ represents the proportional or nonlinear change from one time point to the next. The equation representing change in cognitive performance at age A, without taking into account anxiety, can thus be written as follows:
The equation representing change in anxiety at age A, without taking cognitive performance into consideration, is written as:
. In these models, ␣ is set to a value of 1 while parameter ␤ is estimated. DCSM investigations assume that ␣ and ␤ parameters are consistent across time (Finkel et al., 2009; Finkel et al., 2007) . The univariate DCSMs also estimate the intercepts (anx 0 or cog 0 ), slopes (anx s or cog s ), variance of the intercepts (anx 0 or cog 0 ) and slopes (anx s or cog s ), error deviation (anx or cog ), and correlation between the This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
latent intercept and slope factors. Sex, education, depression, and physical illness were covariates of interest and regressed on the intercept and slope factors. The bivariate DCSM models contain the same parameter estimates as described in the univariate models. The bivariate DCSM models also estimate four additional coupling parameters, designated by ␥, which link the APQ and cognitive performance variables. In bivariate models, the coupling parameters are estimates of how the level of one variable is associated with subsequent change in the other variable. The first coupling parameter estimated how anxiety symptoms were associated with subsequent change in cognitive performance over the following 3 years (␥ anx‫ء‬cog3 ). We then added a second coupling parameter, which is an extension of the original DCSM model (McArdle & Hamagami, 2003) . The second coupling parameter was added to test the length of the follow-up period hypothesis. The second coupling parameter estimated how anxiety was associated with changes in cognitive performance over the 6 years subsequent to the cognitive assessment (␥ anx‫ء‬cog6 ). The third coupling parameter estimated the reverse association: the association between cognitive performance and change in anxiety over the subsequent 3 years (␥ cog‫ء‬anx3 ). The last coupling parameter estimated the association between cognitive performance and change in anxiety over the 6 years subsequent to the anxiety assessment (␥ cog‫ء‬anx6 ). The equation representing the modeling of change in cognitive performance in relation to prior levels of anxiety can be written as
The equation representing the modeling of the change in anxiety in relation to prior levels of cognitive performance can be written as -2] . Similar to the ␣ and ␤ parameters, the ␥ parameters are assumed to be constant across all ages. The bivariate DCSMs also estimate the intercepts (anx 0 and cog 0 ), slopes (anx s and cog s ), variance of the intercepts (anx 0 and cog 0 ) and slopes (anx s and cog s ), error deviations of each variable (anx and cog ), and the correlation between all latent growth factors. Covariates of interest, sex, education, depression, and physical illness were regressed on the intercept and slope factors.
DCSM model comparisons. To examine the significance of parameters, both the probability of parameter estimates and model testing were conducted. A total of seven nested models were compared in a stepwise manner for each anxiety and cognitive domain combination. First, we examined a full model estimating all four coupling parameters: ␥ anx‫ء‬cog6 , ␥ cog‫ء‬anx6 , ␥ anx‫ء‬cog3 , and ␥ cog‫ء‬anx3 . Second, we ran an omnibus test of the coupling parameters by removing all coupling parameters and comparing the nested model fit to the full model. The omnibus test of coupling tests if there is any significant association between anxiety and cognitive performance. The third model examined change in anxiety in association with level of cognitive performance 3 years prior by constraining the ␥ cog‫ء‬anx3 to zero, while the fourth model examined change in cognition in This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
association with level of anxiety 3 years prior (␥ anx‫ء‬cog3 ). Model 5 examined change in cognitive performance as a function of level of anxiety 6 years prior by removing the coupling parameter ␥ anx‫ء‬cog6 . Model 6 examined change in anxiety as a function of level of cognitive performance 6 years prior (␥ cog‫ء‬anx6 ). Model comparisons were conducted using the loglikelihood difference test with the MLR correction for scaling factors (Satorra & Bentler, 2001 ). The MLR correction for scaling factors has to be used because the MLR log likelihood is not distributed as a chi-square. All DCMS models were conducted using the structural equation modeling program MPLUS (Muthén & Muthén, 2010) .
Results
Just over half (58.7%; N ϭ 423) of the participants were women. Table 1 presents the number of participants who contributed data at each age interval. Participants completed an average of 3.5 (SD ϭ 1.9) assessments of anxiety. At initial assessment, the average CESD score was 10.3 (SD ϭ 7.8) and participants had an average of 2.17 (SD ϭ 1.6) medical conditions.
Univariate DCSM
The parameter estimates and overall model fit from the univariate DCSM models are presented in Table 2 . Constant linear change in anxiety symptoms was not statistically significant, although individual differences around this change was present. Proportional and constant linear change was significant for all cognitive variables, except for Digit Span Forward and Digit Span Backward. As a whole, compared to anxiety symptoms, cognitive performance variables exhibited greater mean change and larger individual differences around that change.
Omnibus Test of Coupling Parameters
Across all cognitive measures, the fully adjusted models were not substantially different from the zero-order models without covariates. Therefore, we only present the results from the models adjusting for covariates (see Tables 3-9 ). Fit indices from the full models estimating all four coupling parameters are also presented in these tables. We first conducted an omnibus test of coupling by removing all four coupling parameters for each dynamic model. Across all models, removing these coupling parameters resulted in significantly worse fit compared to the full model. This degradation in fit suggests that a significant dynamic association existed between anxiety and cognitive performance.
Anxiety and Subsequent Changes in Cognitive Performance
Higher anxiety was associated with greater declines in processing speed during 6 years after anxiety was measured. This was true Note. Coupling Anx ¡ Rota ϭ coupling parameter ␥ ANX‫ء‬ROTATIONS ; Coupling Rota ¡ Anx ϭ coupling parameter ␥ ROTATIONS‫ء‬ANX . The 3-year coupling represents change over a 3-year period and 6-year coupling represents change over a 6-year period. Est represents parameter estimate. CFI ϭ comparative fit index; RMSEA ϭ root mean square error of approximation.
This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. Figure 2 . Graphs of the estimated Anxiety Personality Questionnaire and cognitive scores from each of the most parsimonious dual-change score models. Panel A displays the estimated trajectories for anxiety (a1) and symbol digit performance (a2), panel B displays the estimated trajectories for anxiety (b2) and figure identification (b2) performance, panel C displays the estimated trajectories for anxiety (c1) and digit span forward performance (c2), and panel D displays the estimated trajectories for anxiety (d1) and digit span backward performance (d2). Each graph presents estimated trajectories for individuals who scored low (minus 1.5 SD), at the mean, or high (plus 1.5 SD) on either anxiety or respective cognitive measure. This document is copyrighted by the American Psychological Association or one of its allied publishers.
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Cognitive Performance and Subsequent Changes in Anxiety
We next examined the coupling parameters testing the hypothesis that cognitive performance was associated with subsequent changes in anxiety. With the exception of Card Rotations (visuospatial), worse cognitive performance was associated with increases in anxiety across the next 3 years. The largest effects between worse performance and higher anxiety were seen on measures of attention (␥ digits forward‫ء‬anx3 ϭ Ϫ0.29, ⌬fit ϭ 33.27, ⌬df ϭ 1, p Ͻ .01), nonverbal memory (␥ thurstone‫ء‬anx3 ϭ Ϫ0.18, ⌬fit ϭ 9.49, ⌬df ϭ 1, p Ͻ .01), and working memory (␥ digits backward‫ء‬anx3 ϭ Ϫ0.28, ⌬fit ϭ 33.50, ⌬df ϭ 1, p Ͻ .01). Across all cognitive tests, the 6-year coupling between cognitive performance and changes in cognition over the subsequent 6 years was not significant (␥ anx‫ء‬cognition6 , p Ͼ .05).
To visualize the associations between anxiety and each measure of processing speed, we graphed the estimated means of each variable at each age under different scenarios. We first graphed the estimated trajectory of anxiety from ages 50 -86 for individuals at the average, low (Ϫ1.5 SD), and high (ϩ1.5 SD) symbol digit performance. We also estimated the trajectory of performance on each respective cognitive measure for individuals at different levels of initial anxiety (average anxiety, no anxiety, and high anxiety [ϩ1.5 SD]). Figure 2 presents the estimated reported anxiety and each cognitive variable by age.
Discussion
In order to elucidate the temporal dynamics of the association between cognitive performance and anxiety symptoms, bivariate DCSMs were fit to longitudinal data to examine the dynamic relationship between these two variables across older adulthood. Bidirectional associations were present between anxiety symptoms and the cognitive domains of processing speed and attention. Slower processing speed was associated with subsequently larger increases in anxiety 3 years later, whereas higher anxiety was associated with declines in processing speed between years 3 and 6 after the assessment of anxiety. Similarly, for measures of attention, we found that anxiety was a leading indicator of change in attention, with higher anxiety being associated with worsening attention over the following 3 years. We also found that worse performance on measures of processing speed, attention, working memory, nonverbal memory, and visuospatial ability were associated with increasing anxiety 3 years later, with largest effects for nonverbal and working memory. These findings were independent of sex, baseline depressive symptoms, and physical health. The hypothesis of a bidirectional association between cognitive ability and anxiety symptoms was generally supported, with the duration of time being important. Differential associations were present based on length of follow-up period, with poorer cognitive performance being associated with higher anxiety over a shorter follow-up period while anxiety symptoms were associated with worse cognitive performance over a longer period.
The results from the univariate models were consistent with other research suggesting that anxiety symptoms exhibited little mean change with age (Wetherell, Gatz, & Pedersen, 2001) , although significant individual differences in extent of change were present. The univariate models also demonstrated a larger mean change with greater variability for most cognitive performance variables over age compared to anxiety symptoms. The absence of systematic change in anxiety over age makes it more likely that short-term associations would be detected between cognitive performance and very individual changes in anxiety symptoms. The absence of change in anxiety symptoms also made it less likely to detect long-term associations between cognitive performance and changes in anxiety. The presence of systematic change in cognitive performance with significant individual differences around this change over age increased the likelihood that levels of anxiety would be associated with changes in cognitive performance. If differences in the amount of change were solely driving these associations, the levels of anxiety would predict change in cognitive performance over a 3-year interval, given that there was more change in cognitive performance to be explained. Differences between the variables in change over age are a plausible explanation for the different associations between anxiety symptoms and cognitive performance over age; however, this explanation is unlikely.
With respect to cognitive domains, we found that anxiety was associated with greater declines in processing speed and attentional abilities, consistent with other research (Beaudreau & O'Hara, 2009 ). The finding that anxiety is associated with worse processing speed when examined over a longer follow-up period is consistent with past research finding that the effect of emotional distress and cognitive performance is more robust when examined over a longer period of time (Beaudreau & O'Hara, 2008; Byers, Covinsky, Barnes, & Yaffe, 2012) . This association suggests that the negative physiological effect of anxiety on brain health may have a modest effect over a short period of time but may accumulate over longer time periods.
Psychological processes may explain the association between worse cognitive performance and future increases in anxiety symptoms. Noticeable declines in cognitive ability may become a source of worry and distress leading to increased anxiety 3 years later. Declines in cognitive performance may affect social functioning, as these declines may contribute to feeling anxious about performance in social settings. This anxiety may result in avoidance of these situations, thereby reinforcing concerns.
Biological processes may also explain the association between cognition and subsequent increases in anxiety. Possible processes include neurodegenerative processes, cardiovascular disease, or proinflammatory processes that affect cognitive functioning and are followed by anxiety later in the disease process. Recent research has shown that individuals with first onset of anxiety disorders after the age of 50 have elevated proinflammatory processes compared to individuals without anxiety disorders (Vogelzangs, Beekman, de Jonge, & Penninx, 2013) . Multimorbidity, This document is copyrighted by the American Psychological Association or one of its allied publishers.
especially disorders characterized by vascular dysfunction and increased inflammation, has also been shown to be associated with increased risk for anxiety in older adults (Gould, O'Hara, Goldstein, & Beaudreau, 2016) . Genetic factors may also play a role. Prior research has found that genes common to risk of dementia and anxiety were partially mediating the association between higher anxiety and increased risk of dementia . Other recent reviews discuss the many genes in common to both cognitive performance and emotional distress such as anxiety and depression (Rodrigues, Petersen, & Perry, 2014) . Future research needs to identify what these specific genetic factors are and the role that they play in explaining this association. The findings from this study have important implications for cognitive aging research. They highlight the importance of assessing anxiety when conducting cross-sectional and longitudinal studies of cognitive aging. Most studies screen and assess depressive symptoms and dementia; however, few studies adequately assess anxiety symptoms. In a review of 51 longitudinal studies funded by the National Institute on Aging (NIA), anxiety was not identified as a frequently measured component of health and functioning (Stanziano, Whitehurst, Graham, & Roos, 2010) . Similarly, when searching "anxiety" on the NIA's database of longitudinal studies, only three studies were identified as having data on anxiety (compared to eight with depression, nine with personality, and 47 with dementia). Our findings highlight the importance of measuring anxiety in future research on cognitive aging.
Our findings also have important clinical implications such as the importance of psychoeducation of cognitive aging and providing interventions to decrease anxiety in older age. If older adults are educated about normal cognitive aging, they may be less likely to worry about perceived declines in their own current level of functioning. Research suggests that older adults are satisfied with and can improve knowledge through programs designed to increase knowledge about cognitive aging (Norrie et al., 2011) . Another clinical implication includes the potential importance of identifying, preventing, and reducing anxiety and how this may potentially slow the decrease that was seen in processing speed and attention over age. Although it is unclear what physiological mechanisms are driving this association, successful treatment may influence possible physiological mechanisms such as HPA hyperactivation and cardiovascular dysfunction. Successfully treating anxiety may lower cortisol levels (Lenze et al., 2011) , and these changes in cortisol may be beneficial for cognitive performance (Lenze et al., 2012) . Treatment aimed at reducing anxiety might also have beneficial effects on cardiovascular function (e.g., helping to reduce blood pressure), and it is well known that hypertension and other cardiovascular conditions can have negative impacts on brain and cognition (Fennema-Notestine et al., 2016) . Important future research includes examining the long-term impact of treating anxiety on cognitive performance over time and the mechanisms underlying the association. Although it will be important to examine the association between anxiety and cognitive performance in clinically anxious populations, our results indicate that even relatively low levels of anxiety in community-based samples can have deleterious effects on cognitive aging.
Despite the strengths of this study such as a large sample size, number of assessment points, and population-based sample, some limitations should be noted. First, issues exist with the assessment of both anxiety and cognitive performance. The APQ was created via a Rasch harmonization analysis with a more established measure of anxiety (the State Trait Personality Inventory). A more established state-like measurement of anxiety symptoms, such as the anxiety subscale of the Brief Symptom Inventory, may have been more sensitive in capturing the dynamic association over time. Alternatively, it is also possible, however, that the negative impact of anxiety on cognitive performance may not have been present with a state-like measure of anxiety given that this association was only detected when examined over a longer period of time of 6 years. Although the cognitive battery is both reliable and valid, it did not contain measures of verbal memory, problem solving, or executive functions. These domains are domains have been associated with anxiety, and the lack of these in the cognitive battery is a limitation. Last, past research has found interactions between anxiety and depressive symptoms on cognitive performance (Beaudreau & O'Hara, 2009 ), but modeling the interaction between anxiety and depressive symptoms with cognitive performance proved impossible.
In sum, we examined the temporal dynamics between anxiety and cognitive performance in later life. We found evidence of a bidirectional association between anxiety and cognitive performance. For processing speed, anxiety was not associated with declines in cognitive performance 3 years after the assessment but was associated with more delayed changes seen 6 years later. These findings have important clinical implications and highlight the possible usefulness of psychoeducation efforts regarding anxiety in older adults experiencing objective cognitive decline. These findings also highlight the potential importance of treating anxiety as a way to minimize future cognitive performance declines.
